USANA Health Sciences Inc (USNA)
Debt-to-equity ratio
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 497,202 | 470,394 | 468,824 | 455,354 | 434,472 | 411,099 | 403,681 | 389,946 | 395,124 | 399,079 | 418,623 | 402,777 | 441,650 | 389,117 | 349,076 | 317,608 | 351,712 | 314,286 | 384,156 | 391,217 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2023 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $497,202K
= 0.00
Based on the provided data, the debt-to-equity ratio for USANA Health Sciences Inc has consistently been 0.00 across all the reported periods. This indicates that the company does not have any financial leverage through debt in relation to its equity. A debt-to-equity ratio of 0.00 suggests that the company is primarily financed by equity rather than debt, which can be seen as a positive indicator of financial stability and solvency. However, it is important to note that a low debt-to-equity ratio may also imply that the company is missing out on potential tax benefits of debt financing. Overall, the consistency of a 0.00 debt-to-equity ratio over multiple periods suggests that USANA Health Sciences Inc follows a conservative financial strategy with minimal reliance on debt for its operations and growth.